- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
1 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
Johnson & Johnson
Market Cap: US$428.0b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$179.71
7D
2.0%
1Y
11.3%
Biogen
Market Cap: US$19.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$137.37
7D
-3.6%
1Y
-29.4%
Earth Science Tech
Market Cap: US$51.2m
Together with its subsidies, focuses on health and wellness industry.
New
ETST
US$0.17
7D
-6.2%
1Y
-5.5%